Market Access News | pharmaphorum

News

NICE CEO to step down by year-end

Sam Roberts is stepping down from the role of NICE CEO to support her children through a difficult time, and a search for her replacement is underway.

News

AbbVie files to move Venclexta combo into the CLL front line

AbbVie has filed for FDA approval of a new front-line therapy for chronic lymphocytic leukaemia that it thinks could be 'practice changing."

News

Vinay Prasad abruptly departs from the FDA

The disruption at the FDA continues with the departure of CBER director Vinay Prasad, less than three months after taking on the role.

News

Pharma tariffs set to arrive with US-EU trade deal

After some initial confusion, it has been confirmed that the 15% tariff rate on US imports from the EU will extend to pharmaceuticals.

News

Bayer files HER2+ lung cancer drug in China

Bayer files its oral HER2+ lung cancer drug in China, as it extends a race to market with rival Boehringer Ingelheim.

News

Lilly's appeal unlocks EU approval of Alzheimer's drug

Eli Lilly's appeal of a decision by the EMA's human medicines committee not to approve its Alzheimer's disease therapy Kisunla has paid off.

NICE CEO to step down by year-end

AbbVie files to move Venclexta combo into the CLL front line

Vinay Prasad abruptly departs from the FDA

Pharma tariffs set to arrive with US-EU trade deal

Bayer files HER2+ lung cancer drug in China

Lilly's appeal unlocks EU approval of Alzheimer's drug

Pharvaris plans filings for HAE drug after pivotal trial win

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks